507 related articles for article (PubMed ID: 16091118)
1. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization.
Utsunomiya H; Tilakaratne WM; Oshiro K; Maruyama S; Suzuki M; Ida-Yonemochi H; Cheng J; Saku T
J Oral Pathol Med; 2005 Sep; 34(8):498-507. PubMed ID: 16091118
[TBL] [Abstract][Full Text] [Related]
2. The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis.
Bishen KA; Radhakrishnan R; Satyamoorthy K
J Oral Pathol Med; 2008 Aug; 37(7):402-11. PubMed ID: 18298475
[TBL] [Abstract][Full Text] [Related]
3. Distribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF).
Reichart PA; van Wyk CW; Becker J; Schuppan D
J Oral Pathol Med; 1994 Oct; 23(9):394-8. PubMed ID: 7529836
[TBL] [Abstract][Full Text] [Related]
4. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of clinicofunctional staging of oral submucous fibrosis with qualitative analysis of collagen fibers under polarizing microscopy.
Ceena DE; Bastian TS; Ashok L; Annigeri RG
Indian J Dent Res; 2009; 20(3):271-6. PubMed ID: 19884707
[TBL] [Abstract][Full Text] [Related]
6. Nanomechanical signatures of oral submucous fibrosis in sub-epithelial connective tissue.
Anura A; Das D; Pal M; Paul RR; Das S; Chatterjee J
J Mech Behav Biomed Mater; 2017 Jan; 65():705-715. PubMed ID: 27750161
[TBL] [Abstract][Full Text] [Related]
7. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix.
Vleming LJ; Baelde JJ; Westendorp RG; Daha MR; van Es LA; Bruijn JA
Clin Nephrol; 1995 Oct; 44(4):211-9. PubMed ID: 8575119
[TBL] [Abstract][Full Text] [Related]
8. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness.
Bergijk EC; Baelde HJ; de Heer E; Killen PD; Bruijn JA
Exp Nephrol; 1995; 3(6):338-47. PubMed ID: 8528678
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix alterations in human corneas with bullous keratopathy.
Ljubimov AV; Burgeson RE; Butkowski RJ; Couchman JR; Wu RR; Ninomiya Y; Sado Y; Maguen E; Nesburn AB; Kenney MC
Invest Ophthalmol Vis Sci; 1996 May; 37(6):997-1007. PubMed ID: 8631643
[TBL] [Abstract][Full Text] [Related]
10. Oral submucous fibrosis: review on aetiology and pathogenesis.
Tilakaratne WM; Klinikowski MF; Saku T; Peters TJ; Warnakulasuriya S
Oral Oncol; 2006 Jul; 42(6):561-8. PubMed ID: 16311067
[TBL] [Abstract][Full Text] [Related]
11. Expression of extracellular matrix-proteins in perisellar connective tissue and dura mater.
Knappe UJ; Fink T; Fisseler-Eckhoff A; Schoenmayr R
Acta Neurochir (Wien); 2010 Feb; 152(2):345-53; discussion 353. PubMed ID: 19730772
[TBL] [Abstract][Full Text] [Related]
12. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative and immunohistochemical analysis of endothelin-1 in oral submucous fibrosis].
Xu C; Peng X; Liu S; Fang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Dec; 18(6):394-6, 418. PubMed ID: 12539469
[TBL] [Abstract][Full Text] [Related]
14. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
[TBL] [Abstract][Full Text] [Related]
16. An extracellular matrix infrastructure provides support for murine secondary palatal shelf remodelling.
Morris-Wiman J; Brinkley L
Anat Rec; 1992 Dec; 234(4):575-86. PubMed ID: 1280922
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of extracellular matrix components in brush biopsies of oral lesions.
Driemel O; Kosmehl H; Rosenhahn J; Berndt A; Reichert TE; Zardi L; Dahse R
Anticancer Res; 2007; 27(3B):1565-70. PubMed ID: 17595777
[TBL] [Abstract][Full Text] [Related]
18. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
Vedeswari CP; Jayachandran S; Ganesan S
Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
[TBL] [Abstract][Full Text] [Related]
19. Cell death does not herald epithelial involution ("atrophy") in oral sub mucous fibrosis: a TEM study.
Rajendran R; Sunil ; Twinkle SP; Anikumar TV; Annie J
Indian J Dent Res; 2004; 15(1):13-9. PubMed ID: 15682790
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study.
Mishra G; Ranganathan K
Indian J Dent Res; 2010; 21(3):320-5. PubMed ID: 20930336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
